Napodano, Cecilia
 Distribuzione geografica
Continente #
NA - Nord America 2.012
AS - Asia 1.428
EU - Europa 1.381
SA - Sud America 326
AF - Africa 44
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.204
Nazione #
US - Stati Uniti d'America 1.947
SG - Singapore 745
SE - Svezia 427
CN - Cina 321
BR - Brasile 279
IT - Italia 246
DE - Germania 171
FR - Francia 101
IE - Irlanda 99
GB - Regno Unito 94
IN - India 65
VN - Vietnam 64
ID - Indonesia 53
RU - Federazione Russa 48
FI - Finlandia 44
CA - Canada 30
BD - Bangladesh 26
MX - Messico 26
JP - Giappone 25
HK - Hong Kong 23
PL - Polonia 23
BE - Belgio 17
ES - Italia 17
ZA - Sudafrica 17
TR - Turchia 16
KR - Corea 15
IQ - Iraq 14
NL - Olanda 14
UA - Ucraina 14
AR - Argentina 13
AT - Austria 9
CZ - Repubblica Ceca 9
MA - Marocco 9
IR - Iran 8
CI - Costa d'Avorio 7
CO - Colombia 7
EC - Ecuador 7
LT - Lituania 7
PK - Pakistan 7
AU - Australia 6
BY - Bielorussia 6
GR - Grecia 6
NZ - Nuova Zelanda 6
SA - Arabia Saudita 6
DK - Danimarca 5
PT - Portogallo 5
UZ - Uzbekistan 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
CH - Svizzera 4
CL - Cile 4
GY - Guiana 4
KE - Kenya 4
LB - Libano 4
MY - Malesia 4
PY - Paraguay 4
EG - Egitto 3
HU - Ungheria 3
JM - Giamaica 3
KZ - Kazakistan 3
PH - Filippine 3
RO - Romania 3
DZ - Algeria 2
HN - Honduras 2
NP - Nepal 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
BZ - Belize 1
CY - Cipro 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
HT - Haiti 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
ML - Mali 1
MM - Myanmar 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
SV - El Salvador 1
TJ - Tagikistan 1
Totale 5.204
Città #
Chandler 383
Singapore 383
Ashburn 234
New York 121
Dublin 99
Beijing 90
Dallas 79
Rome 72
Los Angeles 59
Jakarta 50
San Mateo 49
Frankfurt am Main 46
Munich 40
Boston 39
Princeton 35
Helsinki 34
Hefei 33
Moscow 33
São Paulo 33
Marseille 32
The Dalles 31
North Bergen 30
Wilmington 30
Chicago 22
Fairfield 22
Hong Kong 22
Tokyo 22
Ho Chi Minh City 21
Cattolica 20
Milan 20
Hanoi 19
Nanjing 19
Houston 18
Orem 15
Redwood City 15
Atlanta 14
Bologna 14
Bremen 14
Castelnuovo di Val di Cecina 14
Dearborn 14
Falls Church 14
Warsaw 14
Boardman 13
Johannesburg 13
London 13
Poplar 13
Stockholm 13
Brussels 12
Chennai 12
Denver 12
Jacksonville 12
Montreal 12
Norwalk 12
Seattle 12
Edinburgh 11
Hyderabad 11
Nuremberg 11
San Francisco 11
Seoul 11
Kent 10
Mexico City 10
Bexley 9
Brooklyn 9
Hebei 9
Woodbridge 9
Amsterdam 8
Querétaro 8
Rio de Janeiro 8
Shenyang 8
Abidjan 7
Ann Arbor 7
Dhaka 7
Falkenstein 7
Manchester 7
Santa Clara 7
Toronto 7
Augusta 6
Baghdad 6
Brno 6
Buffalo 6
Minsk 6
Phoenix 6
Roubaix 6
Auckland 5
Belo Horizonte 5
Curitiba 5
Düsseldorf 5
Lancaster 5
Palermo 5
San Jose 5
Wroclaw 5
Ankara 4
Athens 4
Berlin 4
Cambridge 4
Campinas 4
Casablanca 4
Guangzhou 4
Istanbul 4
Izmir 4
Totale 2.827
Nome #
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 152
Immune dyscrasia in adult growth hormone deficiency: Evaluation of hemolytic complement activity (CH50) and IgG subclasses 152
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 147
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 146
Evaluation of screening method for Bence Jones protein analysis 139
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 139
Immunological role of IgG subclasses 139
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 138
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 131
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 126
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 122
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 121
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 119
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 118
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 117
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 117
Immunological role of IgG subclasses 116
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 116
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 115
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 114
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 111
Free light chains a novel biomarker of cardiovascular disease. A pilot study. 108
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 108
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 105
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 105
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 103
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 100
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 100
The Laboratory Role in anti-TNF Biological Therapy Era 97
Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis 95
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 93
Heavy chain disease: Our experience 93
IgG cryoglobulinemia 93
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 92
Cryoglobulins: putative effectors of adaptive immune response 90
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 90
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 89
Serum free light chain quantitative assays: Dilemma of a biomarker 86
Plasmatic free light chains as inflammatory marker in insulin resistance: comparison of metabolic syndrome with adult growth hormone deficiency 85
COVID-19, adaptative immune response and metabolic-associated liver disease 84
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 83
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 82
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 78
Free light chains and autoimmunity 77
The dark side of current analytic methods for Bence Jones Proteinuria 77
General Practitioner databaSe NAFLD (GPS-NAFLD) Study: preva-lence of advanced liver fibrosis among Italian primary care pa-tients with NAFLD 76
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus 74
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 74
Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD) 68
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 65
Cryoproteins in Non-HCV-Related Autoimmune Disorders: A Serious Cold-Induced Problem 42
Totale 5.307
Categoria #
all - tutte 24.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 4 2 4 10 6 52 41
2021/2022396 11 2 5 69 30 16 11 62 20 16 65 89
2022/20231.131 177 145 74 168 67 118 71 89 119 17 63 23
2023/2024581 31 144 8 54 15 107 46 24 8 25 52 67
2024/20251.144 53 37 83 46 102 52 21 60 172 110 217 191
2025/20261.665 360 57 203 393 532 120 0 0 0 0 0 0
Totale 5.307